Elanco Animal Health Files 8-K

Ticker: ELAN · Form: 8-K · Filed: Jan 13, 2025 · CIK: 1739104

Elanco Animal Health Inc 8-K Filing Summary
FieldDetail
CompanyElanco Animal Health Inc (ELAN)
Form Type8-K
Filed DateJan 13, 2025
Risk Levellow
Pages2
Reading Time2 min
Sentimentneutral

Sentiment: neutral

Topics: sec-filing, 8-k

TL;DR

Elanco filed an 8-K on Jan 13, 2025, standard disclosure stuff.

AI Summary

Elanco Animal Health Incorporated filed an 8-K on January 13, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The filing details the company's principal executive offices located at 2500 Innovation Way, Greenfield, Indiana, 46140, and provides its telephone number as (877) 352-6261. No specific financial figures or material events were detailed in the provided text excerpt.

Why It Matters

This filing serves as an official notification to the SEC and the public about important company events or disclosures, ensuring transparency for investors.

Risk Assessment

Risk Level: low — The provided text is a standard SEC filing notification and does not contain information that would indicate a high-risk event.

Key Players & Entities

  • Elanco Animal Health Incorporated (company) — Filer
  • January 13, 2025 (date) — Date of Earliest Event Reported
  • 2500 Innovation Way, Greenfield, Indiana, 46140 (location) — Address of principal executive offices
  • 877-352-6261 (phone_number) — Registrant's telephone number

FAQ

What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to report a Regulation FD Disclosure and to provide Financial Statements and Exhibits as of January 13, 2025.

What is the exact name of the registrant?

The exact name of the registrant is Elanco Animal Health Incorporated.

In which state was Elanco Animal Health Incorporated incorporated?

Elanco Animal Health Incorporated was incorporated in Indiana.

What is the address of Elanco Animal Health's principal executive offices?

The address of Elanco Animal Health's principal executive offices is 2500 Innovation Way, Greenfield, Indiana, 46140.

What is the registrant's telephone number?

The registrant's telephone number, including area code, is (877) 352-6261.

Filing Stats: 511 words · 2 min read · ~2 pages · Grade level 10.9 · Accepted 2025-01-13 08:31:00

Filing Documents

01 Regulation FD

Item 7.01 Regulation FD. On January 14, 2025, Elanco Animal Health Incorporated (the "Company") will present at the 43rd Annual J.P. Morgan Healthcare Conference (the "JPM Conference"). A copy of the Company's presentation is furnished as Exhibit 99.1. The information in this Item 7.01, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended ("Exchange Act"), or otherwise subject to the liabilities of that Section and shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended, or the Exchange Act, except as otherwise expressly stated in such filing.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Investor Presentation of Elanco Animal Health Incorporated at the JPM Conference. 104.1 Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Elanco Animal Health Incorporated Date: January 13, 2025 By: /s/ Todd Young Name: Todd Young Title: Executive Vice President and Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.